Vir Biotechnology, Inc. Common Stock Share Price
NYSE: VIRHealthcare
Live Vir Biotechnology, Inc. Common Stock Share Price Chart
O H L
Vir Biotechnology, Inc. Common Stock Performance Overview
Days Range
▼
$10.44Low
$10.79High
Markets Today
| Previous Close | $10.92 |
|---|---|
| Open | $10.79 |
| Volume | 6,779,158 |
| Day's Range | $10.44 - $10.79 |
| 52W Range | $4.78 - $11.94 |
| Market Cap | $1.78 B |
Historical Performance
| 1M Returns | +15.07 |
|---|---|
| 3M Returns | +19.21 |
| 6M Returns | +17.17 |
| 1Y Returns | +110.81 |
| 5Y Returns | -79.98 |
| 10Y Returns | NA |
Vir Biotechnology, Inc. Common Stock Fundamentals
| Market Cap | $1.78 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $68.56 M |
| ROE TTM | -0.46 |
| EPS TTM | $-1.86 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.81 |
| EBITDA | $-467.83 M |
| Profit Margin | -638.87 |
| Market Cap | $1.78 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $68.56 M |
| ROE TTM | -0.46 |
| EPS TTM | $-1.86 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.81 |
| EBITDA | $-467.83 M |
| Profit Margin | -638.87 |
Vir Biotechnology, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $3.03 M | $1.21 M | $240.00 K | $64.07 M | -$29.00 K | $238.95 M |
| Gross Profit + | $3.03 M | $1.20 M | $251.00 K | $64.04 M | -$29.00 K | $238.95 M |
| Operating Income | -$139.55 M | -$118.42 M | -$173.44 M | -$47.92 M | -$132.29 M | $73.47 M |
| EBITDA | -$136.69 M | -$115.67 M | -$170.44 M | -$45.02 M | -$129.48 M | $76.27 M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Depreciation | $2.86 M | $2.75 M | $3.00 M | $2.90 M | $2.81 M | $2.80 M |
| Income Before Tax | -$120.95 M | -$110.79 M | -$162.97 M | -$43.06 M | -$125.53 M | $80.26 M |
| Income Tax Expense | $16.00 K | $170.00 K | $168.00 K | -$137.00 K | $170.00 K | $179.00 K |
| Net Income + | -$120.97 M | -$110.96 M | -$163.14 M | -$42.92 M | -$125.69 M | $80.08 M |
| Net Profit Margin | -3989.61% | -9139.87% | -67975.42% | -66.99% | 433431.03% | 33.51% |
Vir Biotechnology, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $14.00 K | $14.00 K | $14.00 K | $14.00 K | $16.00 K | $17.00 K |
| Reserve & Surplus | -$882.72 M | -$993.93 M | -$1.16 B | -$1.20 B | -$1.33 B | -$1.25 B |
| Non-Current Liabilities | $126.62 M | $140.06 M | $148.13 M | $144.73 M | $139.26 M | $137.35 M |
| Current Liabilities | $137.29 M | $105.00 M | $75.22 M | $92.81 M | $73.56 M | $94.96 M |
| Total Liabilities | $263.91 M | $245.06 M | $223.35 M | $237.55 M | $212.82 M | $232.31 M |
| Fixed Assets | $69.75 M | $68.79 M | $66.13 M | $63.47 M | $60.94 M | $58.13 M |
| Current Assets | $932.21 M | $735.71 M | $545.68 M | $514.08 M | $522.99 M | $573.74 M |
| Total Assets | $1.31 B | $1.19 B | $1.02 B | $1.00 B | $1.03 B | $1.21 B |
Vir Biotechnology, Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$120.97 M | -$110.96 M | -$163.14 M | -$42.92 M | -$125.69 M | $80.08 M |
| Operating Cash Flow | -$78.12 M | -$120.22 M | -$167.57 M | -$25.88 M | -$132.39 M | $123.33 M |
| Investing Cash Flow | $126.82 M | $56.46 M | $40.45 M | $86.65 M | $11.84 M | -$197.14 M |
| Financing Cash Flow | $598.00 K | $2.05 M | $102.00 K | $1.04 M | $162.52 M | $78.38 M |
| Change in Cash | $49.30 M | -$61.72 M | -$127.02 M | $61.81 M | $41.97 M | $4.56 M |
Vir Biotechnology, Inc. Common Stock Return Calculator
The Vir Biotechnology, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$1,903
Invested Amount$10,000
Est. Returns$-8,097
About Vir Biotechnology, Inc. Common Stock
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.
Popular Stocks
FAQs
What is the share price of Vir Biotechnology, Inc. Common Stock today?
Vir Biotechnology, Inc. Common Stock (VIR) share price as of September 18, 2026 is $10.38. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Vir Biotechnology, Inc. Common Stock?
Yes, Indian Investors can invest in the Vir Biotechnology, Inc. Common Stock (VIR) Share by opening an international trading account with Angel One.
How can I purchase Vir Biotechnology, Inc. Common Stock shares in India?
Purchasing Vir Biotechnology, Inc. Common Stock (VIR) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Vir Biotechnology, Inc. Common Stock (VIR) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Vir Biotechnology, Inc. Common Stock?
Yes, you can purchase fractional shares of Vir Biotechnology, Inc. Common Stock (VIR) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Vir Biotechnology, Inc. Common Stock?
The market capitalization of Vir Biotechnology, Inc. Common Stock on September 18, 2026, is $1.78 B.
In which sector Vir Biotechnology, Inc. Common Stock belongs?
Vir Biotechnology, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Vir Biotechnology, Inc. Common Stock stocks?
In order to invest in Vir Biotechnology, Inc. Common Stock (VIR) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
